| Literature DB >> 35502050 |
Punita Kumari Sodhi1, Akanksha Gautam1, Nandini Sharma2, Ruchir Rustagi2, Kirti Jaisingh1, Ramneeq Singh Sodhi3.
Abstract
Purpose: The purpose of this study was to assess change of contrast sensitivity (CS) in subjects having retinal diseases with yellow-amber no infrared (NoIR) glasses used as low vision aid (LVA).Entities:
Keywords: Contrast sensitivity; low vision; low vision aid; retinal diseases yellow filter; visual acuity; yellow-amber NoIR glasses
Mesh:
Substances:
Year: 2022 PMID: 35502050 PMCID: PMC9333032 DOI: 10.4103/ijo.IJO_2231_21
Source DB: PubMed Journal: Indian J Ophthalmol ISSN: 0301-4738 Impact factor: 2.969
Figure 1Mean contrast sensitivity scores at pre-LVA and post-LVA
Distribution of eyes having a reduction in CS score values after using yellow-amber NoIR filter
| S. No. of eyes | Age | Disease | Pre-LVA CS | Post-LVA CS |
|---|---|---|---|---|
| 1 | 65/M | Dry ARMD | 0.9 | 0.3 |
| 2 | 50/F | Dry ARMD | 0.9 | 0.3 |
| 3 | 68/M | Wet ARMD | 0.9 | 0.6 |
| 4 | 68/M | Wet ARMD | 0.9 | 0.6 |
| 5 | 65/M | Dry ARMD | 0.9 | 0.3 |
| 6 | 21/M | Hereditary maculopathy | 0.3 | 0.15 |
| 7 | 70/M | Dry ARMD | 0.9 | 0.3 |
| 8 | 67/M | Macular degeneration | 0.9 | 0.3 |
| 9 | 62/M | Pathological myopia | 0.9 | 0.3 |
| 10 | 62/M | Pathological myopia | 0.9 | 0.3 |
| 11 | 20/M | Pathological myopia | 0.3 | 0.15 |
| 12 | 55/M | Diabetic retinopathy | 0.9 | 0.6 |
| 13 | 55/M | Diabetic retinopathy | 0.9 | 0.6 |
| 14 | 49/M | Diabetic retinopathy | 0.6 | 0.3 |
| 15 | 52/M | Macular degeneration | 0.3 | 0.15 |
| 16 | 52/M | Macular degeneration | 0.3 | 0.15 |
| 17 | 62/M | Dry ARMD | 0.9 | 0.6 |
| 18 | 60/F | Dry ARMD | 0.15 | 0 |
| 19 | 20/M | Macular degeneration | 0.15 | 0 |
| 20 | 20/M | Macular degeneration | 0.15 | 0 |
| 21 | 51/M | Vitritis | 0.9 | 0.75 |
Correlation of pre-LVA and post-LVA contrast sensitivity with distance and near BCVA
| CS Score | BCVA Distance | BCVA Near |
|---|---|---|
| Pre-LVA | ||
| Post-LVA (yellow amber NoIR glasses) |
Values of CS in presence/absence of macular optical coherence tomography (OCT) features in LV subjects both at pre-LVA and post-LVA state and statistical significance of difference
| Macular OCT features | Absence/Presence | Mean CS pre-LVA |
| Absence/Presence | Mean CS post-LVA |
|
|---|---|---|---|---|---|---|
| Fluid | No | 0.51±0.29 | 0.562; NSS | No | 0.53±0.29 | 0.705; NSS |
| Yes | 0.55±0.3 | Yes | 0.50±0.26 | |||
| Scar | No | 0.53±0.29 | 0.300; NSS | No | 0.53±0.29 | 0.679; NSS |
| Yes | 0.45±0.27 | Yes | 0.49±0.27 | |||
| PEDa | No | 0.53±0.29 | 0.388; NSS | No | 0.53±0.28 | 0.178; NSS |
| Yes | 0.46±0.29 | Yes | 0.43±0.29 | |||
| Drusens | No | 0.54±0.29 | 0.101; NSS | No | 0.54±0.29 | 0.184; NSS |
| Yes | 0.44±0.26 | Yes | 0.46±0.3 | |||
| ERMb | No | 0.52±0.29 | 0.424; NSS | No | 0.52±0.28 | 0.634; NSS |
| Yes | 0.43±0.28 | Yes | 0.58±0.31 | |||
| Exudates | No | 0.52±0.29 | 0.912; NSS | No | 0.52±0.28 | 0.899; NSS |
| Yes | 0.50±0.35 | Yes | 0.50±0.35 | |||
| CNVMc | No | 0.52±0.29 | 0.454; NSS | No | 0.52±0.28 | 0.438; NSS |
| Yes | 0.30±0.00 | Yes | 0.30±0.00 | |||
| VMTd | No | 0.51±0.29 | 0.525; NSS | No | 0.52±0.29 | 0.878; NSS |
| Yes | 0.60±0.3 | Yes | 0.54±0.25 | |||
| LMHe | No | 0.51±0.29 | 0.135; NSS | No | 0.52±0.29 | 0.441; NSS |
| Yes | 0.83±0.11 | Yes | 0.68±0.11 |
“No” means the absence of OCT feature, and “Yes” means the presence of OCT feature aPigment epithelial detachment; bEpiretinal membranes; cChoroidal neovascular membrane; dVitreomacular traction; eLamellar macular hole
Effect of filters on CS and BCVA
| Authors | Filter | Improvement in CS | Improvement in BCVA with application of filter | |
|---|---|---|---|---|
| 1. | Carracedo | MaxSight Amber contact lens and CSF-Corning 527 glasses filter | Yes; SS | Yes; NSS |
| 2. | Rosenblum | Yellow, amber and orange filters | 27–34% increase | 11-43% increase |
| 3. | Albarran | Seven different color lenses | No | Did not study |
| 4. | Lavric and Pompe[ | Blue filters | Yes; NSS | Yes; SS |
| 5. | Eperjesi and Agelis[ | Corning photochromic filter including CPF450, CPF511, and CPF527 | No (decline seen) | No (decline seen) |
| 6. | Ahmad | Yellow filter | Yes; SS (No improvement in Albinism and Stargardt’s disease) | Did not study |
| 7. | Mahjoob | Yellow filter | Yes | Did not study |
| 8. | Zigman | Short wavelength filters | Yes | Not applicable |
| 7. | Our study | Yellow-amber NoIR filter | No | Did not study; studied correlation values |